- Filed
- May 18, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · May 5, 2023 | 80.52M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2023 | 80.27M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2022 | 32.92M sh |
| Capex | Q1 2023 · Mar 31, 2023 | $17K |
| Capex | Q1 2023 · Mar 31, 2022 | $343K |
| Operating Cash Flow | Q1 2023 · Mar 31, 2023 | −$5.21M |
| Operating Cash Flow | Q1 2023 · Mar 31, 2022 | −$13.26M |
| Long Term Debt | Q1 2023 · Mar 31, 2023 | $1.43M |
| Long Term Debt | Q1 2023 · Dec 31, 2022 | $4.8M |
| Short Term Debt | Q1 2023 · Mar 31, 2023 | $0 |
| Short Term Debt | Q1 2023 · Dec 31, 2022 | $0 |
| Cash And Equivalents | Q1 2023 · Mar 31, 2023 | $18.8M |
| Cash And Equivalents | Q1 2023 · Dec 31, 2022 | $11.44M |
| Stockholders Equity | Q1 2023 · Mar 31, 2023 | $4.17M |
| Stockholders Equity | Q1 2023 · Dec 31, 2022 | $20.82M |
| Stockholders Equity | Q1 2023 · Mar 31, 2022 | $6.62M |
| Stockholders Equity | Q1 2023 · Dec 31, 2021 | $19.07M |
| Current Liabilities | Q1 2023 · Mar 31, 2023 | $5.13M |
| Current Liabilities | Q1 2023 · Dec 31, 2022 | $5.94M |
| Total Liabilities | Q1 2023 · Mar 31, 2023 | $31.55M |
| Total Liabilities | Q1 2023 · Dec 31, 2022 | $12.31M |
| Current Assets | Q1 2023 · Mar 31, 2023 | $32.53M |
| Current Assets | Q1 2023 · Dec 31, 2022 | $23.93M |
| Total Assets | Q1 2023 · Mar 31, 2023 | $35.71M |
| Total Assets | Q1 2023 · Dec 31, 2022 | $33.13M |
| Rd Expense | Q1 2023 · Mar 31, 2023 | $176K |
| Rd Expense restated | Q1 2023 · Mar 31, 2022 | $258K |
| Net Income | Q1 2023 · Mar 31, 2023 | −$17.33M |
| Net Income | Q1 2023 · Mar 31, 2022 | −$13.02M |
| Operating Income | Q1 2023 · Mar 31, 2023 | −$5.01M |
| Operating Income restated | Q1 2023 · Mar 31, 2022 | −$5.41M |
| Cost Of Revenue | Q1 2023 · Mar 31, 2023 | $363K |
| Cost Of Revenue restated | Q1 2023 · Mar 31, 2022 | $131K |
| Revenue | Q1 2023 · Mar 31, 2023 | $620K |
| Revenue restated | Q1 2023 · Mar 31, 2022 | $265K |